Literature DB >> 7784064

Specific c-myc and max regulation in epithelial cells.

C Martel1, D Lallemand, C Crémisi.   

Abstract

We have investigated c-myc, max and c-fos mRNA and protein expression in proliferating, quiescent and stimulated immortalized, SV40 T antigen (LT) transformed and tumor-derived epithelial cells as well in human primary keratinocytes and have compared them to their expression in fibroblasts. In proliferating immortalized and tumor-derived epithelial cells, the levels of c-myc, max and c-fos expression were comparable and much higher than in transformed fibroblasts. c-myc and c-fos mRNA and protein levels remained high even during quiescence, when cells stopped dividing. In contrast, whereas max mRNA was constitutively expressed, max protein levels decreased in both fibroblasts and epithelial cells at high cell density. Changing the medium to serum-free medium of confluent epithelial cells induced a complete proliferative response which started with a transient increase in c-fos and c-myc mRNA, followed by the expression of max. Addition of serum to the medium did not induce additional effects. In fibroblasts, similar treatment induced the arrest of c-myc expression and growth, but max expression was also induced in these cells by serum. Our results therefore show that max expression is growth regulated in both immortalized and transformed epithelial as well as fibroblast cells. In contrast, in epithelial cells, c-myc displayed two contrasting behaviors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784064

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  2 in total

1.  RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.

Authors:  E Batsché; C Muchardt; J Behrens; H C Hurst; C Crémisi
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

2.  Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network.

Authors:  J K R Boult; P Tanière; M T Hallissey; M J Campbell; C Tselepis
Journal:  Br J Cancer       Date:  2008-05-20       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.